Prescient (ASX:PTX) share price sinks despite positive update

The biotech company's shares are taking a fall today after reaching a multi-year high yesterday.

falling healthcare asx share price Mesoblast capital raising

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Prescient Therapeutics Ltd (ASX: PTX) share price is freefalling today after the company provided an update on its next-generation immunotherapy platform.

At the time of writing, the Prescient share price has fallen 11%, trading at 20 cents.

Let's take a look at the clinical stage oncology company's news out today.

What did Prescient announce?

Investors are selling Prescient shares after the biotech announced it has completed a CAR-T manufacturing milestone. CAR-T cell therapy is a form of immunotherapy that uses laboratory altered T cells to fight cancer.

In today's release, Prescient advised it has successfully incorporated SpyTag into a range of binders for its next-generation CAR-T programs. This includes the OmniCAR system, a breakthrough CAR T therapy platform that is believed to be a more safe and effective treatment when treating cancers.

In addition to the update, Prescient also received delivery of lentiviral vectors that will be used to produce CAR-T cells expressing SpyCatcher.

Both the binders and lentiviral vectors have been delivered to the Peter MacCallum Cancer Centre in Melbourne. Testing and in vitro (using live culture) and in vivo (using a living organism) development is expected to be undertaken.

Prescient CEO and managing director Steven Yatomi-Clarke commented:

Demonstrating that novel components can be manufactured is a crucial milestone in the development of an innovative next-generation CAR platform like OmniCAR.

… Prescient's research team at the Peter Mac has completed all the preparatory work in parallel, and the delivery of the binders and vectors now enables the team to progress the development of our in-house next-generation cell therapies.

About the Prescient share price

Established in 1986, Prescient focuses on developing novel, personalised therapies for a range of cancers. This includes cancers such as Acute Myeloid Leukemia (AML), glioblastoma multiforme (GBM), as well as breast, ovarian and gastric cancers.

Despite today's fall, the Prescient share price is up more than 185% in 2021, and has lifted 233% over the last 12 months. The company's shares reached a multi-year high of 23 cents yesterday.

Prescient presides a market capitalisation of roughly $144 million, with approximately 640 million shares on issue.

More on Healthcare Shares

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 small-cap ASX healthcare shares 'with strong prospects'

Fund manager IML discusses why these 3 ASX healthcare shares are likely to rise in value.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

2 All Ords ASX healthcare shares making BIG moves on quarterly updates

These two ASX healthcare companies are seeing heavy trading on Thursday.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

'Trading at a discount': Why now is the time to buy CSL shares

This investing expert says CSL shares now represent an appealing buying opportunity.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

Here's what could impact CSL shares from the biotech's AGM

The biotech giant's leadership had plenty to say.

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

Why this fundie is backing ResMed shares in FY25

There's plenty more upside, this fund says.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Healthcare Shares

ResMed shares jump 8% on stellar start to FY25

This high-quality company continues to deliver the goods.

Read more »

Senior woman with caregiver in the garden
Healthcare Shares

A 'golden era' is coming for these ASX healthcare shares

Here's why Blackwattle Partners sees tailwinds ahead for one particular category of healthcare shares.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Guess which ASX 200 healthcare stock is rising on big FDA news

Some big news is giving this stock a major lift on Thursday.

Read more »